How much does afamelanotide cost (and why does the price vary)?
Afamelanotide (brand name Scenesse in many markets) is typically priced as an administered therapy rather than an OTC drug, so the “price” a patient sees can depend on country, clinic billing practices, and insurance coverage. The provided information doesn’t include any specific cost figure for afamelanotide, so a precise price cannot be stated here.
What affects the out-of-pocket cost for patients?
Even when the drug’s list price is known, patient cost often changes based on:
- Country and local reimbursement rules
- Whether it’s covered by insurance or national health systems
- Clinic administration fees and bundled service pricing
- Patient eligibility criteria (afamelanotide is used for a specific condition, and payers often require documentation)
Is afamelanotide covered by insurance or reimbursed?
Coverage varies by health system and indication criteria. Without country-specific details and no provided reimbursement data, it isn’t possible to say whether afamelanotide is covered where you live or what percentage is typically paid by the patient.
Can I find the exact price for my country?
To give an exact figure, I need at least one detail: your country (or the country where you’ll buy it). Afamelanotide prices can differ significantly across regions, so the right number depends on location.
Tell me what you need and I’ll narrow it down
Reply with:
1) Your country, and
2) Whether you want list price, insurance copay estimates, or cash price (self-pay).
With that, I can focus on the most relevant “afamelanotide price” you’re trying to find.